Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

HQL - abrdn Life Sciences Investors


Close
13.52
-0.030   -0.222%

Share volume: 1,460
Last Updated: Thu 26 Dec 2024 08:29:01 PM CET

PREVIOUS CLOSE
CHG
CHG%

$13.55
-0.03
-0.22%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Performance
5 Days
0.97%
1 Month
-2.30%
3 Months
-9.33%
6 Months
-3.34%
1 Year
0.82%
2 Year
-5.49%
Key data
Stock price
$13.52
P/E Ratio 
0.00
DAY RANGE
$13.55 - $13.61
EPS 
$0.00
52 WEEK RANGE
$12.84 - $15.90
52 WEEK CHANGE
$0.37
MARKET CAP 
413.813 M
YIELD 
10.53%
SHARES OUTSTANDING 
27.351 M
DIVIDEND
$0.49
EX-DIVIDEND DATE
08/23/2024
NEXT EARNINGS DATE
N/A
BETA 
0.72
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$144,481
AVERAGE 30 VOLUME 
$99,009
Company detail
CEO: Dan O. PhD
Region: US
Website: teklacap.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry:
Sector:

Tekla Life Sciences Investors is a closed-ended equity mutual fund. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector.

Recent news